M Calabresi
Overview
Explore the profile of M Calabresi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crisman G, Margiotta G, Calabresi M, Discepoli S, Leocata P
Pathologe
. 2015 Jun;
36(4):385-8.
PMID: 26055331
According to the most recent World Health Organization (WHO) guidelines a diagnosis of malignant fibrous histiocytoma (MFH) should be made only for lesions composed of tumor cells without evidence of...
2.
Mills R, Calabresi M, Tennant A, Young C
Mult Scler
. 2012 Aug;
19(4):502-5.
PMID: 22917692
The determination of the minimum clinically important difference (MCID) is an important aspect of scale development. The Neurological Fatigue Index for multiple sclerosis (NFI-MS) was administered before and after expected...
3.
Geiger A, Calabresi M
Yale J Biol Med
. 2011 Mar;
17(5):635-55.
PMID: 21434233
No abstract available.
4.
5.
Caccia C, Maj R, Calabresi M, Maestroni S, Faravelli L, Curatolo L, et al.
Neurology
. 2006 Oct;
67(7 Suppl 2):S18-23.
PMID: 17030736
Ideal treatment in Parkinson's disease (PD) aims at relieving symptoms and slowing disease progression. Of all remedies, levodopa remains the most effective for symptomatic relief, but the medical need for...
6.
Veneroni O, Maj R, Calabresi M, Faravelli L, Fariello R, Salvati P
Pain
. 2003 Mar;
102(1-2):17-25.
PMID: 12620593
NW-1029, a benzylamino propanamide derivative, was selected among several molecules of this chemical class on the basis of its affinity for the [(3)H]batracotoxin ligand displacement of the Na(+) channel complex...
7.
Schafer M, Schwaeble W, Post C, Salvati P, Calabresi M, Sim R, et al.
J Immunol
. 2000 May;
164(10):5446-52.
PMID: 10799911
Recent evidence suggests that the pathophysiology of neurodegenerative and inflammatory neurological diseases has a neuroimmunological component involving complement, an innate humoral immune defense system. The present study demonstrates the effects...
8.
Speciale C, Cini M, Wu H, Salvati P, Schwarcz R, Molinari A, et al.
Adv Exp Med Biol
. 1996 Jan;
398:221-7.
PMID: 8906269
No abstract available.
9.
Casciola L, Costa A, Bececco D, De Matteis F, Squeo S, Proietti Silvestri G, et al.
Minerva Chir
. 1993 Oct;
48(19):1053-8.
PMID: 8309601
The paper broadly outlines the technique of laparoscopic cholecystectomy used by the authors to treat patients suffering from calculosis of the gallbladder. Basing their comments on the French school, the...
10.
Salvati P, Dho L, Calabresi M, Rosa B, Patrono C
Eur J Pharmacol
. 1992 Oct;
221(2-3):267-73.
PMID: 1426005
Inhibition of endothelin-1 (ET-1)-converting enzyme has been suggested as a strategy for blocking ET-1-mediated vasoconstriction. However, it is unclear whether its putative substrate, bigET-1, is an inactive precursor. Thus, we...